Status:
COMPLETED
Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Replacement Therapy, Renal
Eligibility:
All Genders
18+ years
Brief Summary
In a prospective, non-interventional, monocentric observational study the pharmacokinetic properties of selected antiinfective drugs during sustained low-efficiency dialysis (SLED) will be analyzed.
Detailed Description
Antibiotic concentrations are measured whilst patients receive SLED for renal replacement therapy. The plasma specimens will be quantified using high Performance liquid chromatography (HPLC). Primary...
Eligibility Criteria
Inclusion
- age: 18 or older
- patients receiving SLED and either meropenem or ceftazidim
Exclusion
- missing informed consent
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT02287493
Start Date
July 1 2013
End Date
December 1 2016
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Hamburg-Eppendorf
Hamburg, Germany, 20246